Clinical Trial Update: Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of pioglitazone on insulin resistance, atherosclerosis progression, and clinical course of coronary heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Heart Disease
• Insulin Resistance Syndrome

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Ukrainian Medical Stomatological Academy | Conditions: Adverse Effect, Atherosclerosis, Coronary | Phase 4 | Status: COMPLETED | Results posted: 2022-03-10